Photo of Dr. Hagop Kantarjian from obroncology.com
Mar 4, 2024, 10:16
Hagop Kantarjian: Gamma delta T cells, a novel immunotherapy for AML
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center,shared a post on X/Twitter:
“Gamma delta T cells are a novel immunotherapy for AML. Recent review from our group. We have clinical trials w Aza Ven and gd2T cell activating ICT01 for Newly Dx AML, & allogeneic gd1T cells for R/R AML”
Source: Hagop Kantarjian/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19